Dr. Kabraji is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2017
Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
Oxford University Medical SchoolClass of 2009
Certifications & Licensure
MA State Medical License 2012 - 2025
NY State Medical License 2023 - 2025- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy.Chiara Corti, Busem Binboğa Kurt, Beyza Koca, Tasnim Rahman, Fabio Conforti
Cancer Treatment Reviews. 2024-11-13 - 2 citationsPure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.Albert Grinshpun, Douglas Russo, Wen Ma, Ana Verma, Francisco Hermida-Prado
NPJ Breast Cancer. 2024-06-08 - 1 citationsRAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta
Clinical Cancer Research. 2024-04-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
